Clinical Trials Logo

Clinical Trial Summary

This is a 6-visit, single-center, non-dispensing, randomized, single-masked, 5×5 crossover study. Subjects will participate in 6 scheduled over the duration of approximately 10.5 months.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04811079
Study type Interventional
Source Johnson & Johnson Vision Care, Inc.
Contact
Status Completed
Phase N/A
Start date July 14, 2021
Completion date May 16, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04520217 - Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects Phase 1
Completed NCT04654312 - Study to Evaluate the Influence of Hydrochlorothiazide on Dermal Photosensitivity and DNA Stability - a Pilot Study (HCTox Study) Phase 1
Completed NCT01942564 - The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study N/A